Obesity Prevalence in the United States — Up, Down, or Sideways?

Abstract

Successful development of future targeted therapies will require the flexibility to rapidly evaluate combination regimens involving new targeted agents in a single development program. The FDA has therefore developed draft guidance on drug co-development.